Please login to the form below

Not currently logged in
Email:
Password:

Fishawack buys JK Associates

Healthcare comms agency adds US-based group to portfolio

The JK brands JK Medical Communications, Arbor Communications, Endpoint Medical Communications and 1010 Digital will work alongside Fishawack's Philadelphia team.

“Along with what is now Fishawack Communications, this is our second US acquisition,” said Oliver Dennis, CEO of the Fishawack Group.

“Clients want integrated agencies that can work together across geographies on global accounts. When we discussed the synergies between us it was obvious – Fishawack needed more depth in the US and JK needed a European-based team with greater resources.”

JK Associates president and CEO John (Zeke) Czekanski and COO Kevin Pawley will continue managing their company's day-to-day operations, and will join the Fishawack board. The two organisations first worked together in 2004, on a joint business pitch.

“Our business model is to have critical mass co-located with our clients with UK-based support for when scale is needed,” said Fishawack group managing director Gail Flockhart.

“This means that in medical communications, the ideal agency profile is one with critical mass in three key locations: the US, the UK, and Switzerland. Fishawack is truly unique in this regard.”

Established 13 years ago, the Fishawack Group of Companies has offices in the UK (near Manchester and Oxford), the US (North Wales and Conshohocken, PA, and Ann Arbor, MI), and Switzerland (Basel and Zofingen).

Fishawack works with pharma, biotechnology and medical device companies, providing services such as medical communications, scientific engagement, market access, clinical and regulatory writing, and pharmacovigilance support.

Article by
Tara Craig

4th April 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics